Stroke patients with dementia treated with intravenous thrombolysis using powerful clot-busting drugs are at no higher risk of brain haemorrhage or death than other patients receiving the same treatment, a study from Karolinska Institutet published in the journal Neurology reports.
After a campaign by scientists, the Irish government announces membership of European Southern Observatory, operator of some of the biggest telescopes in the world
The Commission has for the first time made clear the position of UK grantees after Brexit, in a sign the EU is laying the ground for the UK to leave without a deal
Employees are lukewarm on new locations and a slow-down in work rate will mean less income. In the best case scenario Europe’s drugs regulator will take 2-3 years to get back to speed after leaving London.
The stand-off is over, but with prime minister Viktor Orbán’s campaign against CEU founder George Soros heating up and the Commission pursuing its legal case against Hungary’s law on foreign NGOs, a deal may still be in doubt
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.